Filipinos looking for exposure to the global healthcare sector, think pharmaceutical giants, medical device makers, and diagnostics companies, don’t need a foreign brokerage account to do it. The ATRAM Global Health Care Feeder Fund is a peso-denominated Unit Investment Trust Fund (UITF) that gives local investors a straightforward way to ride the long-term growth of the worldwide health care industry, accessible through platforms like GCash, Maya, Seedbox, and COL Financial.
Here’s a full breakdown of what the fund holds, how it performs, its fees, and how to get started.
What Is the ATRAM Global Health Care Feeder Fund?
Launched on December 14, 2021, the fund is managed by ATRAM Trust Corporation and classified as Moderately Aggressive. As a feeder fund, it doesn’t buy individual stocks directly. Instead, it channels investor money into a single foreign “target fund” that does the actual stock picking.
Key fund facts:
- Bloomberg Ticker: ATRGHCP
- Currency: PHP
- Minimum Initial Investment: ₱100
- Minimum Additional Investment: ₱100
- Minimum Holding Period: None
- Early Redemption Charge: None
- Dealing Day: Daily, with a 2:00 PM cut-off
- Settlement: Typically T+5 to T+7 business days for redemptions
- Benchmark: MSCI ACWI Health Care Index, Net Dividends
What Does It Invest In? The Target Fund
The fund feeds into the Fidelity Funds – Global Healthcare Fund, managed by FIL Investment (Luxembourg) S.A. This target fund has been around since September 1, 2000 and manages roughly USD 1.24 billion in assets. It invests in equity securities of companies worldwide involved in the design, manufacture, or sale of products and services used in health care, medicine, or biotechnology.
As of the latest available data, the target fund was 99.1% invested in equities, with the small remainder held in cash.
Top Holdings of the ATRAM Global Health Care Feeder Fund
Based on the target fund’s top ten holdings (as of April 30, 2026), the portfolio leans heavily on established pharmaceutical, medtech, and managed care names:
- Roche Holding AG – 7.4%
- Eli Lilly & Co – 6.5%
- AbbVie Inc – 6.4%
- UnitedHealth Group Inc – 6.2%
- AstraZeneca PLC – 6.2%
- Stryker Corp – 5.2%
- Novartis AG – 4.9%
- Gilead Sciences Inc – 4.3%
- Thermo Fisher Scientific Inc – 3.6%
- McKesson Corp – 3.3%
Together, these ten names make up roughly 54% of the fund’s holdings, so the fund’s short-term performance can swing quite a bit based on how just a handful of large pharma and medtech companies are doing.
Sector Breakdown
The underlying sector exposure shows the fund is not purely a “biotech” or “pharma” bet, but a blend across the whole health care value chain:
- Pharmaceuticals: 38.7%
- Health Care Equipment & Supplies: 17.8%
- Health Care Providers & Services: 15.3%
- Biotechnology: 14.9%
- Life Sciences Tools & Services: 11.8%
Regional Exposure
Geographically, the fund is dominated by US-listed companies, but keeps meaningful exposure to Europe:
- United States: 59.9%
- Switzerland: 15.3%
- United Kingdom: 9.5%
- Germany: 3.8%
- Belgium: 3.2%
- Denmark: 2.8%
- Japan: 2.2%
- Israel: 1.9%
- China: 0.6%
This roughly 40% non-US allocation is worth noting. Investors expecting a fund that mirrors purely American healthcare names (like Johnson & Johnson or Pfizer specifically) will find a more globally diversified mix here, with heavyweight Swiss (Roche, Novartis) and British (AstraZeneca) names taking large slices of the pie.
Fees and Expenses
Because this is a feeder fund, you’re paying two layers of cost:
- Trust Fee (local, ATRAM level): around 1.16% p.a., already deducted before the daily NAVPU is published, so you don’t pay this separately
- Total Expense Ratio (target fund level): around 1.05% p.a.
There are no early redemption charges and no minimum holding period, so you can redeem anytime without penalty. Note that ATRAM’s fee tables are periodically updated, so it’s worth double-checking the latest Key Information and Investment Disclosure Statement (KIIDS) on atram.com.ph or your investing app before committing large amounts.
Performance and Risk
The fund’s NAVPU and returns move daily along with global healthcare stock prices, and healthcare as a sector tends to be more defensive than something like tech, but it’s not immune to volatility. Because the fund is peso-denominated while the target fund is in US Dollars, your returns are also affected by USD/PHP exchange rate movements, on top of how the underlying stocks perform.
Given the concentration in a handful of large holdings and the currency exposure, this fund fits investors who:
- Have a moderately aggressive risk appetite
- Are comfortable with equity fund volatility
- Have a medium-to-long-term investment horizon (think years, not months)
- Want diversified exposure to the global health care sector without picking individual foreign stocks
How to Invest in the ATRAM Global Health Care Feeder Fund
1. Invest via GCash GFunds
GCash’s Invest Money feature, powered by ATRAM, lists this fund among its available GFunds. You can start with as little as ₱1,000 depending on the fund listing, browse the fund page for the current NAVPU and performance chart, and buy directly in the app.
2. Invest via Maya Funds
Maya Funds runs on the Investa Funds and Seedbox Funds platforms, and the ATRAM Global Health Care Feeder Fund is available on both, confirmed by fact sheets hosted directly on Investa’s own platform as well as Seedbox. So whichever side of Maya you’re on, this fund should be accessible.
3. Invest via Seedbox
Seedbox Philippines offers a more investment-focused interface for accessing ATRAM funds directly, useful if you’re planning to hold several ATRAM funds as part of a diversified portfolio rather than just this one.
4. Invest via COL Financial Fund Source
COL Financial users may also access selected ATRAM feeder funds, including this one, through the Fund Source feature.
Whichever platform you use, always check the fund’s current NAVPU, minimum investment amount, and latest KIIDS before buying, since minimums and fees can vary slightly by platform and unit class.
Frequently Asked Questions
Is the ATRAM Global Health Care Feeder Fund a good investment for beginners?
It can work for beginners who already understand basic equity fund risk and want sector-specific exposure. It’s not a starter fund for someone who has never invested before, since a single-sector fund is more volatile than a broadly diversified equity fund.
What is the minimum investment for this fund?
Based on ATRAM’s official disclosure statement, the minimum initial and additional investment is ₱100 each, though this may differ slightly depending on the platform (GCash, Maya, Seedbox, or COL Financial) you use.
Does this fund invest directly in US healthcare stocks?
Not directly. It feeds into the Fidelity Funds – Global Healthcare Fund, which then buys the individual stocks. About 60% of that target fund’s exposure is to US companies, with the rest spread across Europe, Japan, and other markets.
Can I lose money in this fund?
Yes. Like any equity UITF, your investment isn’t guaranteed and its value fluctuates with the market. There is no capital protection, and losses are for the account of the investor.
How do I redeem my investment?
You can redeem anytime since there’s no minimum holding period or early redemption charge, though settlement typically takes T+5 to T+7 business days depending on your platform.
Blogger’s Corner
I get asked a lot about healthcare funds kasi parang “safe” siya sound, medical naman ang tema eh, hindi ba dapat stable lang? Pero as you can see sa breakdown, malaki pa rin yung concentration sa top holdings, so hindi rin siya immune sa ups and downs. What I like about this fund is yung diversification across pharma, medtech, at biotech, hindi lang isang sub-sector. Kung naniniwala ka sa long-term theme ng aging global population (and I do), this is one of the more straightforward ways para ma-access mo yun without needing a US brokerage account.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Fund data, holdings, and fees are based on ATRAM’s official disclosure documents at the time of writing and may have changed since publication. Always check the latest fund fact sheet and consult a licensed financial advisor before investing.